Press Releases

Biotechnology Instruments Market Size to Worth Around USD 206.7 Bn by 2030

Share This Article

The global Biotechnology Instruments market is expected to grow at a CAGR of around 20.60% over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 206.7 billion by 2030.

Download Exclusive Sample of Report@

Growth Factors

  The growth in the biotechnology industry can also be attributed to several factors such as the launch of new and innovative products, agreements, acquisitions, technological advancements, and increasing adoption in various applications. Rising demand for POC devices in the home and other healthcare settings to cater to the elderly population and increasing government initiatives to shorten hospital stays by establishing outpatient care models are expected to drive the demand for POC diagnostics over the next six years.

Report Coverage

Report Scope Details
Market Size USD 206.7 billion by 2030
Growth Rate CAGR of 20.60% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott; Agilent Technologies; Alcon, Inc.; AngioDynamics; Becton, Dickinson, and Company; BioMerieux SA; Bio-Rad Laboratories; BioTek Instruments, Inc.; Candela Medical; Cynosure, LLC; Danaher Corporation; Endress+Hauser (Analytik Jena GmbH); F. Hoffmann-La Roche Ltd.; IIlumina Inc.; IRIDEX; Lumenis; Merck KGaA; Novanta,  Inc.; Perkin Elmer, Inc.; QIAGEN

Report Highlights

The life science consumables segment dominated the market in 2020 with a revenue share of over 65.0% and is expected to grow at the fastest rate over the forecast period. The launch of new PCR test kits is expected to be a major driver for the segment. Medical lasers have emerged as a lucrative market space, primarily due to their expanding applications. Medical lasers have been used predominantly in various surgical procedures.

Hospitals and healthcare facilities accounted for the largest revenue share of over 55.0% in 2020. COVID-19 has fueled the demand for IVD point-of-care devices in hospitals. Recent advancements in IVD instruments have made them convenient to use and highly efficient, which has raised their adoption across healthcare settings.

North America captured the largest revenue share of over 50.0% in 2020 owing to the high demand and affordability of biotechnology instrumentation. In addition, the inclination toward manual automation in the biotechnology, pharmaceuticals, and related industries in the region is boosting the demand for advanced and sophisticated instruments to ease and accelerate the process.

The COVID-19 pandemic has created a need for rapid diagnostic assays and self-testing kits, and several companies are actively fulfilling these requirements. In December 2020, Shimadzu Corporation launched fully automated PCR testing AutoAmp Genetic Analyzer (AutoAmp) in Japan. This enhanced the COVID-19 testing capabilities of clinics in Japan.

Key Players

  • Abbott
  • Agilent Technologies
  • Alcon, Inc.
  • AngioDynamics
  • Becton, Dickinson, and Company
  • BioMerieux SA
  • Bio-Rad Laboratories
  • BioTek Instruments, Inc.
  • Candela Medical
  • Cynosure, LLC
  • Danaher Corporation
  • Endress+Hauser (Analytik Jena GmbH)
  • F. Hoffmann-La Roche Ltd.
  • IIlumina Inc.
  • Lumenis
  • Merck KGaA
  • Novanta, Inc.
  • Perkin Elmer, Inc.
  • Siemens  Healthineers
  • Tecan Group AG
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
  • Zimmer MedizinSysteme

Market Segmentation

  • Product
    • Lab Automation Instruments
      • Proteomics
      • Genomics
      • Sequencing
      • Spatial Cell Analysis
      • Others
    • Life Science Consumables
    • IVD Instruments
    • Medical Lasers
      • Therapeutics
      • Ophthalmic
      • Ablation
  • End-use
    • Government & Academic Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Healthcare Facilities
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa
      • Saudi Arabia

Buy this Research Report study@

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape        List of Suppliers        List of Buyers

Chapter 7.  Global Biotechnology Instruments Market, By Product

7.1.  Biotechnology Instruments Market, by Product, 2021-2030

7.1.1.    Lab Automation Instruments        Market Revenue and Forecast (2017-2030)

7.1.2.    Life Science Consumables        Market Revenue and Forecast (2017-2030)

7.1.3.    IVD Instruments        Market Revenue and Forecast (2017-2030)

7.1.4.    Medical Lasers        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Biotechnology Instruments Market, By End-use

8.1.  Biotechnology Instruments Market, by End-use, 2021-2030

8.1.1.    Government & Academic Institutes        Market Revenue and Forecast (2017-2030)

8.1.2.    Pharmaceutical & Biotechnology Companies        Market Revenue and Forecast (2017-2030)

8.1.3.    Hospitals & Healthcare Facilities        Market Revenue and Forecast (2017-2030)

8.1.4.    Others        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Biotechnology Instruments Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2017-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.1.3.    U.S.        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.1.4.    Rest of North America        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2017-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.2.3.    UK        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.2.4.    Germany        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.2.5.    France        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.2.6.    Rest of Europe        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2017-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.3.3.    India        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.3.4.    China        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.3.5.    Japan        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.3.6.    Rest of APAC        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2017-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.4.3.    GCC        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.4.4.    North Africa        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.4.5.    South Africa        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.4.6.    Rest of MEA        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2017-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.5.3.    Brazil        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

9.5.4.    Rest of LATAM        Market Revenue and Forecast, by Product (2017-2030)        Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10.  Company Profiles

10.1.              Abbott

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Agilent Technologies

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Alcon, Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              AngioDynamics

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Becton, Dickinson, and Company

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              BioMerieux SA

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Bio-Rad Laboratories

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              BioTek Instruments, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Candela Medical

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Cynosure, LLC

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Danaher Corporation

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Endress+Hauser (Analytik Jena GmbH)

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           F. Hoffmann-La Roche Ltd.

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           IIlumina Inc.

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

10.15.           IRIDEX

10.15.1.               Company Overview

10.15.2.               Product Offerings

10.15.3.               Financial Performance

10.15.4.               Recent Initiatives

10.16.           Lumenis

10.16.1.               Company Overview

10.16.2.               Product Offerings

10.16.3.               Financial Performance

10.16.4.               Recent Initiatives

10.17.           Merck KGaA

10.17.1.               Company Overview

10.17.2.               Product Offerings

10.17.3.               Financial Performance

10.17.4.               Recent Initiatives

10.18.           Novanta, Inc.

10.18.1.               Company Overview

10.18.2.               Product Offerings

10.18.3.               Financial Performance

10.18.4.               Recent Initiatives

10.19.           Perkin Elmer, Inc

10.19.1.               Company Overview

10.19.2.               Product Offerings

10.19.3.               Financial Performance

10.19.4.               Recent Initiatives

10.20.           QIAGEN

10.20.1.               Company Overview

10.20.2.               Product Offerings

10.20.3.               Financial Performance

10.20.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Buy this Research Report study@

Contact Us:

Vision Research Reports

Call: +1 9197 992 333


Show More

Related Articles

Back to top button